# FDA Inspection 1067782 - Bal Raj Bhandari, M.D. - September 20, 2018

Source: https://www.keypedia.com/records/fda_inspections/bal-raj-bhandari-md/62e0d3c7-75e9-419b-a44b-b819d09da034
Source feed: FDA_Inspections

> FDA Inspection 1067782 for Bal Raj Bhandari, M.D. on September 20, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1067782
- Company Name: Bal Raj Bhandari, M.D.
- Inspection Date: 2018-09-20
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1102916 - 2019-08-29](https://www.keypedia.com/records/fda_inspections/bal-raj-bhandari-md/1d5e4630-8384-4119-9ad3-ce358fbfdb69)
- [FDA Inspection 791204 - 2012-07-12](https://www.keypedia.com/records/fda_inspections/bal-raj-bhandari-md/1a21ea2d-f6ee-49b5-aaed-3062f85424e2)
- [FDA Inspection 768531 - 2012-01-20](https://www.keypedia.com/records/fda_inspections/bal-raj-bhandari-md/26dc9d84-fbc0-460e-87e9-7bd9f53654d8)

Company: https://www.keypedia.com/companies/bal-raj-bhandari-md/7ec065ba-9e7c-4555-b2e3-2fa6fb9de6e2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c